An optimised patient-derived explant platform for breast cancer reflects clinical responses to chemotherapy and antibody-directed therapy.

Although there were only 4 BC-PDEs with a HER2 score of 3 + , relative to FET treatment alone, there was a significant trend towards higher tumour apoptosis and tumour apoptosis/necrosis dependent on HER2 status (Fig. 6 B).

also in 9,775 other papers